Sticking With This Microsoft Price Target After AI Chief Sends Safety Warning
A bevy of analysts have updated their outlook on Microsoft shares today.
One of My Top Small-Cap Biotech Picks Made a Move. Here’s How I Trade It
The FDA just granted this biopharma name a key designation. Let me show you in detail how I handle a stock like this.
We’ve Got Our Eye on the ‘Sky’ as a New Position
Here’s our trading plan for the $10,000 Portfolio as we begin the week.
Call Me Foolish, But I See Some Potential Market Catalysts Emerging
Ahead of a big China meeting, and what could be a meeting with Iran’s leadership, let’s see why clouds appear to be parting over Wall St.
Just When I Thought Complacency Had Been Pushed Off the Table, It’s Back.
Finally, investors started to show some concern on Thursday, but by Friday, they were back and getting excited about the semis, which concerns me.
How to Buy the Uber Dip With a Covered-Call Strategy
Channeling Peter Lynch to invest in the rideshare giant.
Bearish Bets: 3 Stocks Getting Hammered With Little Chance to Recover
How to short three stocks that cannot keep up with a bullish market.
Weekly Roundup: September Is Living Up to Its Reputation
During the week of challenging developments, we refreshed out shopping list, exited one holding and added to four others.
Don’t Confuse Speculation With a Healthy Turn
When the best-performing stocks on your screen are micro-cap junk and crypto, that is just money chasing action.
When Warren Buffett Called the Trading Floor
‘Hello, this is Warren.’ Why Buffett’s two calls to the trading floor left me starstruck and how I view Berkshire stock as the Oracle of Omaha steps aside.